المؤلفون: Xiao FK; Oncology Department, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. xfkw@hotmail.com., Wang L; Internet Medical and System Applications of National Engineering Laboratory, First Affiliated Hospital of Zhengzhou University, 1 Jianshe East Road, Zhengzhou, 450052, Henan, China.

المصدر: Molecular biotechnology [Mol Biotechnol] 2024 Aug; Vol. 66 (8), pp. 2087-2094. Date of Electronic Publication: 2023 Aug 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: Switzerland NLM ID: 9423533 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-0305 (Electronic) Linking ISSN: 10736085 NLM ISO Abbreviation: Mol Biotechnol Subsets: MEDLINE

مواضيع طبية MeSH: Esophageal Neoplasms*/genetics , Esophageal Neoplasms*/metabolism , Esophageal Neoplasms*/pathology , Tumor Necrosis Factor Receptor Superfamily, Member 7*/metabolism , Tumor Necrosis Factor Receptor Superfamily, Member 7*/genetics , Gene Expression Regulation, Neoplastic* , Biomarkers, Tumor*/metabolism , Biomarkers, Tumor*/genetics, Humans ; Cell Line, Tumor ; Prognosis ; Signal Transduction ; Cell Proliferation ; Proto-Oncogene Mas

المؤلفون: Eguren-Santamaría I; Combination Strategies for Translational Immunotherapy, Immunology and Immunotherapy Program, Centro de Investigación Médica Aplicada (CIMA) Universidad de Navarra, Pamplona, Spain.; Medical Oncology Department, Clínica Universidad de Navarra, Pamplona, Spain.; Immunology, Navarra Institute for Health Research (IdiSNA), Pamplona, Spain., Rodríguez I; Combination Strategies for Translational Immunotherapy, Immunology and Immunotherapy Program, Centro de Investigación Médica Aplicada (CIMA) Universidad de Navarra, Pamplona, Spain.; Immunology, Navarra Institute for Health Research (IdiSNA), Pamplona, Spain., Herrero-Martin C; Combination Strategies for Translational Immunotherapy, Immunology and Immunotherapy Program, Centro de Investigación Médica Aplicada (CIMA) Universidad de Navarra, Pamplona, Spain.; Immunology, Navarra Institute for Health Research (IdiSNA), Pamplona, Spain., Fernández de Piérola E; Combination Strategies for Translational Immunotherapy, Immunology and Immunotherapy Program, Centro de Investigación Médica Aplicada (CIMA) Universidad de Navarra, Pamplona, Spain.; Immunology, Navarra Institute for Health Research (IdiSNA), Pamplona, Spain., Azpilikueta A; Combination Strategies for Translational Immunotherapy, Immunology and Immunotherapy Program, Centro de Investigación Médica Aplicada (CIMA) Universidad de Navarra, Pamplona, Spain.; Immunology, Navarra Institute for Health Research (IdiSNA), Pamplona, Spain., Sánchez-Gregorio S; Combination Strategies for Translational Immunotherapy, Immunology and Immunotherapy Program, Centro de Investigación Médica Aplicada (CIMA) Universidad de Navarra, Pamplona, Spain.; Immunology, Navarra Institute for Health Research (IdiSNA), Pamplona, Spain., Bolaños E; Combination Strategies for Translational Immunotherapy, Immunology and Immunotherapy Program, Centro de Investigación Médica Aplicada (CIMA) Universidad de Navarra, Pamplona, Spain.; Immunology, Navarra Institute for Health Research (IdiSNA), Pamplona, Spain., Gomis G; Combination Strategies for Translational Immunotherapy, Immunology and Immunotherapy Program, Centro de Investigación Médica Aplicada (CIMA) Universidad de Navarra, Pamplona, Spain.; Immunology, Navarra Institute for Health Research (IdiSNA), Pamplona, Spain., Molero-Glez P; Combination Strategies for Translational Immunotherapy, Immunology and Immunotherapy Program, Centro de Investigación Médica Aplicada (CIMA) Universidad de Navarra, Pamplona, Spain.; Immunology, Navarra Institute for Health Research (IdiSNA), Pamplona, Spain., Chacón E; Gynecology & Obstetrics Department, Clínica Universidad de Navarra, Pamplona, Spain., Mínguez JÁ; Gynecology & Obstetrics Department, Clínica Universidad de Navarra, Pamplona, Spain., Chiva S; Urology Department, Clínica Universidad de Navarra, Pamplona, Spain., Diez-Caballero F; Urology Department, Clínica Universidad de Navarra, Pamplona, Spain., de Andrea C; Immunology, Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Pathology Department, Clínica Universidad de Navarra, Pamplona, Spain., Teijeira Á; Combination Strategies for Translational Immunotherapy, Immunology and Immunotherapy Program, Centro de Investigación Médica Aplicada (CIMA) Universidad de Navarra, Pamplona, Spain.; Immunology, Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Spanish Center for Biomedical Research Network in Oncology (CIBERONC), Madrid, Spain., Sanmamed MF; Combination Strategies for Translational Immunotherapy, Immunology and Immunotherapy Program, Centro de Investigación Médica Aplicada (CIMA) Universidad de Navarra, Pamplona, Spain.; Medical Oncology Department, Clínica Universidad de Navarra, Pamplona, Spain.; Immunology, Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Spanish Center for Biomedical Research Network in Oncology (CIBERONC), Madrid, Spain., Melero I; Immunology, Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Spanish Center for Biomedical Research Network in Oncology (CIBERONC), Madrid, Spain.; Department of Immunology and Immunotherapy, Clínica Universidad de Navarra, Pamplona, Spain.; Nuffield Department of Medicine, University of Oxford, Oxford, UK.

المصدر: Oncoimmunology [Oncoimmunology] 2024 Jul 09; Vol. 13 (1), pp. 2373519. Date of Electronic Publication: 2024 Jul 09 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE

مواضيع طبية MeSH: Tumor Necrosis Factor Receptor Superfamily, Member 9*/agonists , Tumor Necrosis Factor Receptor Superfamily, Member 9*/metabolism , Tumor Necrosis Factor Receptor Superfamily, Member 9*/immunology , Immunotherapy*/methods, Animals ; Mice ; Humans ; Programmed Cell Death 1 Receptor/antagonists & inhibitors ; Programmed Cell Death 1 Receptor/metabolism ; Programmed Cell Death 1 Receptor/immunology ; Female ; Neoplasms/immunology ; Neoplasms/therapy ; Neoplasms/drug therapy ; Neoplasms/pathology ; Interferon-gamma/metabolism ; Antibodies, Monoclonal/pharmacology ; Antibodies, Monoclonal/therapeutic use ; Tumor Cells, Cultured ; Mice, Inbred C57BL ; Immune Checkpoint Inhibitors/pharmacology ; Immune Checkpoint Inhibitors/therapeutic use

المؤلفون: Wiesheu R; School of Cancer Sciences, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.; Cancer Research UK Scotland Institute, Glasgow, UK., Edwards SC; School of Cancer Sciences, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.; Cancer Research UK Scotland Institute, Glasgow, UK., Hedley A; Cancer Research UK Scotland Institute, Glasgow, UK., Hall H; Cancer Research UK Scotland Institute, Glasgow, UK., Tosolini M; Cancer Research Centre of Toulouse, University of Toulouse, Toulouse, France., Fares da Silva MGF; Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark., Sumaria N; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK., Castenmiller SM; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department Of Hematopoiesis, Sanquin Research, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Wardak L; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department Of Hematopoiesis, Sanquin Research, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Optaczy Y; Cancer Research UK Scotland Institute, Glasgow, UK., Lynn A; School of Cancer Sciences, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.; Cancer Research UK Scotland Institute, Glasgow, UK., Hill DG; School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Hayes AJ; School of Infection & Immunity, University of Glasgow, Glasgow, UK., Hay J; School of Cancer Sciences, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, UK., Kilbey A; School of Cancer Sciences, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.; Cancer Research UK Scotland Institute, Glasgow, UK., Shaw R; Cancer Research UK Scotland Institute, Glasgow, UK., Whyte D; Cancer Research UK Scotland Institute, Glasgow, UK., Walsh PJ; Cancer Research UK Scotland Institute, Glasgow, UK., Michie AM; School of Cancer Sciences, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, UK., Graham GJ; School of Infection & Immunity, University of Glasgow, Glasgow, UK., Manoharan A; School of Cancer Sciences, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, UK., Halsey C; School of Cancer Sciences, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, UK., Blyth K; School of Cancer Sciences, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.; Cancer Research UK Scotland Institute, Glasgow, UK., Wolkers MC; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department Of Hematopoiesis, Sanquin Research, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Miller C; School of Cancer Sciences, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.; Cancer Research UK Scotland Institute, Glasgow, UK., Pennington DJ; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK., Jones GW; School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Fournie JJ; Cancer Research Centre of Toulouse, University of Toulouse, Toulouse, France., Bekiaris V; Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark., Coffelt SB; School of Cancer Sciences, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, UK. Seth.Coffelt@glasgow.ac.uk.; Cancer Research UK Scotland Institute, Glasgow, UK. Seth.Coffelt@glasgow.ac.uk.

المصدر: The EMBO journal [EMBO J] 2024 Jul; Vol. 43 (14), pp. 2878-2907. Date of Electronic Publication: 2024 May 30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8208664 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2075 (Electronic) Linking ISSN: 02614189 NLM ISO Abbreviation: EMBO J Subsets: MEDLINE

مواضيع طبية MeSH: Antigens, Ly*/metabolism , Antigens, Ly*/genetics , Tumor Necrosis Factor Receptor Superfamily, Member 7*/metabolism , Tumor Necrosis Factor Receptor Superfamily, Member 7*/genetics , Tumor Necrosis Factor Receptor Superfamily, Member 7*/immunology , Receptors, Antigen, T-Cell, gamma-delta*/metabolism , Receptors, Antigen, T-Cell, gamma-delta*/immunology , Receptors, Antigen, T-Cell, gamma-delta*/genetics, Animals ; Mice ; Humans ; Interferon-gamma/metabolism ; Interferon-gamma/immunology ; Interleukin-27/metabolism ; Interleukin-27/genetics ; Cell Differentiation/immunology ; Mice, Inbred C57BL ; T-Lymphocytes, Cytotoxic/immunology ; T-Lymphocytes, Cytotoxic/metabolism

المؤلفون: Solórzano JL; Pathology and Molecular Department, MD Anderson Cancer Center, Madrid, Spain.; Translational Research Department, MD Anderson Foundation, Madrid, Madrid, Spain., Menéndez V; Translational Research Department, MD Anderson Foundation, Madrid, Madrid, Spain., Parra E; Department of Translational Molecular Pathology, MD Anderson Cancer Center, Houston, Houston, TX, USA., Solis L; Department of Translational Molecular Pathology, MD Anderson Cancer Center, Houston, Houston, TX, USA., Salazar R; San Agustin National University, Arequipa, Peru., García-Cosío M; Pathology Department, Hospital Ramón y Cajal, Madrid, Spain., Climent F; Pathology Department, Hospital Universitari de Bellvitge, IDIBELL, L'Hospitalet De Llobregat, Barcelona, Spain., Fernández S; Pathology and Molecular Department, MD Anderson Cancer Center, Madrid, Spain., Díaz E; Translational Research Department, MD Anderson Foundation, Madrid, Madrid, Spain., Francisco-Cruz A; Pathology Department, National Institute of Cardiology Ignacio Chavez, México DF, Mexico., Khoury J; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA., Jiang M; Department of Translational Molecular Pathology, MD Anderson Cancer Center, Houston, Houston, TX, USA., Tamegnon A; Department of Translational Molecular Pathology, MD Anderson Cancer Center, Houston, Houston, TX, USA., Montalbán C; Translational Research Department, MD Anderson Foundation, Madrid, Madrid, Spain., Melero I; University of Navarra and Instituto de Investigación Sanitaria de Navarra, Pamplona, Navarra, Spain., Wistuba I; Department of Translational Molecular Pathology, MD Anderson Cancer Center, Houston, Houston, TX, USA., De Andrea C; University of Navarra and Instituto de Investigación Sanitaria de Navarra, Pamplona, Navarra, Spain., F García J; Pathology and Molecular Department, MD Anderson Cancer Center, Madrid, Spain.; Translational Research Department, MD Anderson Foundation, Madrid, Madrid, Spain.

المصدر: Oncoimmunology [Oncoimmunology] 2024 Aug 10; Vol. 13 (1), pp. 2388304. Date of Electronic Publication: 2024 Aug 10 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE

مواضيع طبية MeSH: Hodgkin Disease*/pathology , Hodgkin Disease*/immunology , Hodgkin Disease*/metabolism , Tumor Necrosis Factor Receptor Superfamily, Member 9*/metabolism , Tumor Microenvironment*/immunology , Myeloid-Derived Suppressor Cells*/metabolism , Myeloid-Derived Suppressor Cells*/immunology , Myeloid-Derived Suppressor Cells*/pathology , Reed-Sternberg Cells*/pathology , Reed-Sternberg Cells*/metabolism, Humans ; Female ; Male ; Adult ; Middle Aged ; Aged ; Spatial Analysis ; Young Adult ; Lymphocytes, Tumor-Infiltrating/immunology ; Lymphocytes, Tumor-Infiltrating/metabolism ; Adolescent ; Prognosis ; Biomarkers, Tumor/metabolism

المؤلفون: Puppala ER; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland Baltimore School of Medicine, Baltimore, MD, 21201, USA., Wu L; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland Baltimore School of Medicine, Baltimore, MD, 21201, USA., Fan X; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland Baltimore School of Medicine, Baltimore, MD, 21201, USA.; Department of Microbiology and Immunology, University of Maryland Baltimore School of Medicine, Baltimore, MD, 21201, USA., Cao X; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland Baltimore School of Medicine, Baltimore, MD, 21201, USA. XuefangCao@som.umaryland.edu.; Department of Microbiology and Immunology, University of Maryland Baltimore School of Medicine, Baltimore, MD, 21201, USA. XuefangCao@som.umaryland.edu.

المصدر: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2024 Aug 06; Vol. 73 (10), pp. 198. Date of Electronic Publication: 2024 Aug 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

مواضيع طبية MeSH: CD8-Positive T-Lymphocytes*/immunology , CD8-Positive T-Lymphocytes*/metabolism , Melanoma, Experimental*/immunology , Melanoma, Experimental*/pathology , Signal Transduction* , Tumor Necrosis Factor Receptor Superfamily, Member 7*/metabolism, Animals ; Mice ; Disease Models, Animal ; Lung Neoplasms/secondary ; Lung Neoplasms/pathology ; Lung Neoplasms/immunology ; Lung Neoplasms/metabolism ; Lung Neoplasms/genetics ; Mice, Inbred C57BL ; Mice, Knockout ; Neoplasm Metastasis

المؤلفون: Imianowski CJ; Department of Pathology, University of Cambridge, Cambridge, United Kingdom., Kuo P; Department of Pathology, University of Cambridge, Cambridge, United Kingdom.; Immunology Programme, Babraham Institute, Babraham Research Campus, Cambridgeshire, United Kingdom., Whiteside SK; Department of Pathology, University of Cambridge, Cambridge, United Kingdom., von Linde T; Department of Pathology, University of Cambridge, Cambridge, United Kingdom., Wesolowski AJ; Department of Pathology, University of Cambridge, Cambridge, United Kingdom., Conti AG; Department of Pathology, University of Cambridge, Cambridge, United Kingdom., Evans AC; Department of Pathology, University of Cambridge, Cambridge, United Kingdom., Baird T; Department of Pathology, University of Cambridge, Cambridge, United Kingdom., Morris BI; Department of Pathology, University of Cambridge, Cambridge, United Kingdom., Fletcher NE; Department of Pathology, University of Cambridge, Cambridge, United Kingdom., Yang J; Department of Pathology, University of Cambridge, Cambridge, United Kingdom.; Immunology Programme, Babraham Institute, Babraham Research Campus, Cambridgeshire, United Kingdom., Poon E; F-Star Therapeutics, Babraham Research Campus, Cambridgeshire, United Kingdom., Lakins MA; F-Star Therapeutics, Babraham Research Campus, Cambridgeshire, United Kingdom., Yamamoto M; Department of Immunoparasitology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.; Laboratory of Immunoparasitology, WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan.; Department of Immunoparasitology, Center for Infectious Disease Education and Research, Osaka University, Osaka, Japan., Brewis N; F-Star Therapeutics, Babraham Research Campus, Cambridgeshire, United Kingdom., Morrow M; F-Star Therapeutics, Babraham Research Campus, Cambridgeshire, United Kingdom.; invoX Pharma, Cambridge, United Kingdom., Roychoudhuri R; Department of Pathology, University of Cambridge, Cambridge, United Kingdom.

المصدر: Cancer research communications [Cancer Res Commun] 2024 Aug 01; Vol. 4 (8), pp. 2045-2057.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE

مواضيع طبية MeSH: T-Lymphocytes, Regulatory*/drug effects , T-Lymphocytes, Regulatory*/immunology , Receptors, OX40*/agonists , Receptors, OX40*/immunology , Tumor Necrosis Factor Receptor Superfamily, Member 9*/agonists , Interferon-gamma*/metabolism , Antibodies, Bispecific*/pharmacology , Antibodies, Bispecific*/therapeutic use, Animals ; Mice ; Mice, Inbred C57BL ; Humans ; Cell Line, Tumor ; Female

المؤلفون: Dou Z; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.; Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China., Bonacci TR; Department of Genetics, University of North Carolina, Chapel Hill, NC, USA., Shou P; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA., Landoni E; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA., Woodcock MG; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.; Division of Oncology, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Sun C; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA., Savoldo B; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.; Department of Pediatrics, University of North Carolina, Chapel Hill, NC, USA., Herring LE; Michael Hooker Proteomics Center, Department of Pharmacology, University of North Carolina, Chapel Hill, NC, USA., Emanuele MJ; Department of Genetics, University of North Carolina, Chapel Hill, NC, USA., Song F; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA., Baldwin AS; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.; Department of Genetics, University of North Carolina, Chapel Hill, NC, USA., Wan Y; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.; Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC, USA., Dotti G; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. gdotti@med.unc.edu.; Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC, USA. gdotti@med.unc.edu., Zhou X; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. zhouxin@email.unc.edu.; Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC, USA. zhouxin@email.unc.edu.

المصدر: Cellular & molecular immunology [Cell Mol Immunol] 2024 Aug; Vol. 21 (8), pp. 905-917. Date of Electronic Publication: 2024 Jun 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Chinese Society of Immunology;; _b Nature Pub. Group Country of Publication: China NLM ID: 101242872 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2042-0226 (Electronic) Linking ISSN: 16727681 NLM ISO Abbreviation: Cell Mol Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Receptors, Chimeric Antigen*/metabolism , Receptors, Chimeric Antigen*/genetics , Tumor Necrosis Factor alpha-Induced Protein 3*/metabolism , Tumor Necrosis Factor alpha-Induced Protein 3*/genetics , Tumor Necrosis Factor Receptor Superfamily, Member 9*/metabolism , Cell Death*, Humans ; Animals ; Necroptosis ; Apoptosis ; Signal Transduction ; Mice ; NF-kappa B/metabolism ; Cell Line, Tumor ; Ubiquitin/metabolism

المؤلفون: Yi L; Department of Central Laboratory, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China., Yan J; Department of Clinical Laboratory, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China., Wei P; Department of Central Laboratory, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China., Long S; Department of Clinical Laboratory, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China., Wang X; Department of Central Laboratory, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China., Gu M; Department of Central Laboratory, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China., Yang B; Department of Clinical Laboratory, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China., Chen Y; Department of Clinical Laboratory, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China., Ma S; Department of Clinical Laboratory, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China., Wang C; Department of Clinical Laboratory, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China., Zheng M; Department of Clinical Laboratory, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China., Sun Q; National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China., Shi Y; Department of Clinical Laboratory, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China., Wang G; Department of Clinical Laboratory, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China.

المصدر: European journal of immunology [Eur J Immunol] 2024 Aug; Vol. 54 (8), pp. e2350796. Date of Electronic Publication: 2024 Jun 25.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 1273201 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-4141 (Electronic) Linking ISSN: 00142980 NLM ISO Abbreviation: Eur J Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Tumor Necrosis Factor Receptor Superfamily, Member 9*/blood , Biomarkers*/blood , Tuberculosis, Pulmonary*/blood , Tuberculosis, Pulmonary*/immunology , Tuberculosis, Pulmonary*/mortality , Severity of Illness Index*, Humans ; Male ; Female ; Middle Aged ; Prognosis ; Adult ; Aged ; Cytokines/blood ; Tuberculosis, Pleural/immunology ; Tuberculosis, Pleural/blood ; Tuberculosis, Pleural/diagnosis ; Tuberculosis, Pleural/mortality

المؤلفون: Mauhin W; Internal Medicine Department, Reference Center for Lysosomal Diseases, Groupe Hospitalier Diaconesses-Croix Saint Simon, Paris, France.; Centre de Recherche en Myologie, Unité Mixte de Recherche Scientifique 974, Sorbonne Université, Institut National de la Santé et de la Recherche Médicale, Paris, France., Dzangue-Tchoupou G; Centre de Recherche en Myologie, Unité Mixte de Recherche Scientifique 974, Sorbonne Université, Institut National de la Santé et de la Recherche Médicale, Paris, France., Amelin D; Centre de Recherche en Myologie, Unité Mixte de Recherche Scientifique 974, Sorbonne Université, Institut National de la Santé et de la Recherche Médicale, Paris, France., Corneau A; Plateforme de Cytométrie de la Pitié-Salpétrière (CyPS), UMS037-PASS, Faculté de Médecine, Sorbonne Université, Paris, France., Lamari F; UF Biochimie des Maladies Neuro-métaboliques, Service de Biochimie Métabolique, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Paris, France., Allenbach Y; Centre de Recherche en Myologie, Unité Mixte de Recherche Scientifique 974, Sorbonne Université, Institut National de la Santé et de la Recherche Médicale, Paris, France., Dussol B; Nephrology Department, Aix Marseille Université et Centre d'Investigation Clinique 1409, INSERM/AMU/AP-HM, Marseille, France., Leguy-Seguin V; Internal Medicine and Clinical Immunology Department, Francois Mitterrand Hospital, Dijon, France., D'Halluin P; Nephrology and Hemodialysis Department, Centre Hospitalier Côte Basque, Bayonne, France., Matignon M; Nephrology and Renal Transplantation Department, Institut Francilien de Recherche en Néphrologie et Transplantation (IFRNT), Henri-Mondor/Albert-Chenevier University Hospital, Assistance Publique Hôpitaux de Paris, Créteil, France., Maillot F; Internal Medicine Department, Tours University Hospital, Tours, France., Ly KH; Internal Medicine Department, Dupuytren University Hospital, Limoges, France., Besson G; Neurology Department, Grenoble University Hospital, Grenoble, France., Willems M; Medical Genetics and Rare Diseases Department, Montpellier University Hospital, Montpellier, France., Labombarda F; Cardiology Department, Caen University Hospital, Caen, France., Masseau A; Internal Medicine Department, Hôtel-Dieu University Hospital, Nantes, France., Lavigne C; Internal Medicine and Clinical Immunology Department, Angers University Hospital, Angers, France., Lacombe D; Medical Genetics Department, CHU de Bordeaux, INSERM U1211, Université de Bordeaux, Bordeaux, France., Maillard H; Department of Internal Medicine and Clinical Immunology, Referral Centre for rare systemic autoimmune diseases North and North-West of France (CeRAINO), CHU Lille, Lille, France., Lidove O; Internal Medicine Department, Reference Center for Lysosomal Diseases, Groupe Hospitalier Diaconesses-Croix Saint Simon, Paris, France., Benveniste O; Centre de Recherche en Myologie, Unité Mixte de Recherche Scientifique 974, Sorbonne Université, Institut National de la Santé et de la Recherche Médicale, Paris, France.

المصدر: Journal of inherited metabolic disease [J Inherit Metab Dis] 2024 Jul; Vol. 47 (4), pp. 818-833. Date of Electronic Publication: 2024 Apr 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 7910918 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2665 (Electronic) Linking ISSN: 01418955 NLM ISO Abbreviation: J Inherit Metab Dis Subsets: MEDLINE

مواضيع طبية MeSH: Fabry Disease*/immunology , Trihexosylceramides*/metabolism , CD4-Positive T-Lymphocytes*/immunology , Tumor Necrosis Factor Receptor Superfamily, Member 7*/metabolism, Humans ; Male ; Adult ; Middle Aged ; Young Adult ; Adolescent ; Sphingolipids/metabolism ; Case-Control Studies ; Leukocyte Common Antigens ; Memory T Cells/immunology ; Memory T Cells/metabolism ; Flow Cytometry ; CD28 Antigens ; Immunologic Memory ; Receptors, CCR7/metabolism ; Glycolipids

المؤلفون: Kopp A; Department of Chemical Engineering, University of Michigan, 2800 Plymouth Rd., Ann Arbor, Michigan, 48109, USA., Guan J; Department of Chemical Engineering, University of Michigan, 2800 Plymouth Rd., Ann Arbor, Michigan, 48109, USA., Johnston C; Crescendo Biologics, Cambridge, UK., Vance S; Crescendo Biologics, Cambridge, UK., Legg J; Crescendo Biologics, Cambridge, UK., Galson-Holt L; Crescendo Biologics, Cambridge, UK., Thurber GM; Department of Chemical Engineering, University of Michigan, 2800 Plymouth Rd., Ann Arbor, Michigan, 48109, USA. gthurber@umich.edu.; Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan, 48109, USA. gthurber@umich.edu.; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, 48109, USA. gthurber@umich.edu.

المصدر: The AAPS journal [AAPS J] 2024 Jun 11; Vol. 26 (4), pp. 68. Date of Electronic Publication: 2024 Jun 11.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association of Pharmaceutical Scientists Country of Publication: United States NLM ID: 101223209 Publication Model: Electronic Cited Medium: Internet ISSN: 1550-7416 (Electronic) Linking ISSN: 15507416 NLM ISO Abbreviation: AAPS J Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Bispecific*/pharmacology , Antibodies, Bispecific*/immunology , Tumor Necrosis Factor Receptor Superfamily, Member 9*/immunology , T-Lymphocytes*/immunology , T-Lymphocytes*/drug effects , Lymphocyte Activation*/drug effects , Programmed Cell Death 1 Receptor*/immunology, Humans ; Cross-Linking Reagents/chemistry ; Drug Design